PREPA PREvention of Loss of Autonomy (PREPA)

September 8, 2025 updated by: Hospices Civils de Lyon

Prevention Study on Loss of Autonomy and Physical Dependence, Based on Physical Exercises and Nutrition Counseling Applied to Old People.

According to several reports, the proportion of people aged 80yrs or older will be doubled within the next 25y, reaching 10% of the global population. Furthermore, the health life expectancy at 65y is 10.4y which remains much lower than the general life expectancy. As a result, there is a constant need of developing preventive strategies through multimodal programs.

Among the predictive factors of mobility disability with age, muscular weakness and decreased physical function are major components. These two factors are known of being responsible for falls and fractures that lead to decrease the quality of life and an increase in mortality.

Exercise and nutrition are the only components that have proven their efficacy to struggle mobility disability risk. It is important to integrate these two components in a sustained intervention within a multidimensional prevention program. However, there is a lack of implementation of these programs in primary care.

Indeed, neither the screening of older adults at risk of mobility disability, nor the preventive actions are usually implemented for this population. The implementation of a prevention care pathway, with personalized intervention and a sustained follow-up, along with supervised exercise training combined with nutritional counselling, is the public health imperatives.

Based on prevention care pathway that designed for community-dwelling older adults screened at risk of mobility disability. The purpose of this open cohort study was to highlight the efficacy and the feasibility of a multimodal program implemented on real-life setting specifically on the physical function and risk of mobility loss, along with their maintenance at 6-months and 1-year follow-up.

Study Overview

Detailed Description

Two groups will be identified :

A first group with a SPPB (Short physical performance battery) score between 8 and 10 and walking more than 90 minutes per week. They will be asked to carry out 2 to 3 times a week a series of exercises concerning the main muscle groups, using bodyweight, and without specific equipment. An activity booklet will be given as support. In a complementary way, individual objectives will be established to develop endurance by fighting against hyper-sedentariness based on simple advice to the patient and his entourage. The volume of physical activity will be developed from activities of daily living. A telephone coaching will be carried out every 4 weeks by a Adapted Physical Activity Monitor and a precise evaluation of the physical performances will be carried out at 3 months.

A second group for patients with Short physical performance battery ≤ 8 or if >8 but excessive sedentary walking less than 90 minutes per week, including running, or having sarcopenia criteria.

They will be offered bi-weekly care by a Adapted Physical Activity Monitor. Training will be conducted either in small group programs or at home (if unable to attend), at the frequency of 2 sessions per week for 10 weeks. The personalized program of muscular reinforcement will be of progressive intensity with and without additional load and with very simple and easily usable devices including at home (elastic bands, weights. . . ).

During the dedicated geriatric consultation, the nutritional status will also be evaluated by a food survey and biological samples in order to measure the usual serum nutritional markers. The objective of the assessment is to ensure an adequate intake of macro nutrients, including proteins, and energy; as well as micronutrient fruits and vegetables rich in antioxidants and omega 3 fatty acids which also have a significant impact in terms of prevention and muscle function.

Loss of autonomy : (ADL) Activities of Daily Living score will be calculated. This validated scale requires 3 evaluations spread over time. A score > 6 indicates an addiction.

(Instrumental Activities of Daily Living) Lawton's IADL scale is essentially focused on the person's usual behaviour and essentially assesses a patient's level of dependence through the assessment of activities of daily living.

Useful for assessing the patient's state of functional autonomy and deciding on appropriate aids (meals at home, household helper, life support, legal protection).

Study Type

Interventional

Enrollment (Estimated)

530

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pierre-Bénite, France, 69495
        • Service de Médecine Gériatrique Groupement Hospitalier Sud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient eligible for the "mobility loss prevention" program
  • At least one of the following signs:

    • Difficulty carrying a loaded shopping basket (about 4.5 kg)
    • Difficulty rising from a chair without using the arms
    • Difficulty climbing one flight of stairs (10 steps)
    • Difficulty moving around
    • Slowed walking
    • Difficulty walking more than 400 meters without stopping
    • Walking time < 30 minutes/day
    • Fatigue during mild physical efforts: running errands, household chores; fear of falling and/or at least one fall in the past year
    • Recent unintentional weight loss: weight loss ≥ 5% in 6 months or BMI < 22 kg/m²

Exclusion Criteria:

  • Patient who has not given consent to participate
  • Patient under guardianship in retrospective phase
  • Locomotor disability
  • expectancy of life being under 12 months
  • BMI ≥ 35 Kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Multicomponent group-based supervised exercise program
Community-dwelling older adults aged of >70y, screened at risk of mobility disability risk factors and assessed with at least 1 mobility disability risk factor (see intervention 1). These subjects are included in the protocol and participate in a multicomponent exercise program.

Evaluation carried out during a day hospital at T0 (initial assessment) and T3 following the exercise program including:

  1. Clinical assessment by a geriatrician
  2. Nutritional assessment
  3. Physical capacity assessment

Following initial assessment (T0), older adults are included in the multicomponent exercise program if they present mobility disability risk factors including :

  • At least pre-frailty regarding Fried frailty criteria AND/OR
  • At least probable sarcopenia regarding EWGSOP2 algorithm AND/OR
  • The presence of at least an intermediate fall risk AND/OR
  • The presence of a fear of falling Following the exercise program (T3), all participants are re-assessed in the same way as T0. Investigators then set goals in physical activity with participants to maintain benefits and foster self-engagement in an healthy lifestyle. Additionnally, participants are orientated to exercise facilities and received an individualized booklet of exercises for home-based training.
The intervention consists in a progressive multicomponent exercise training protocol. There are 2 sessions per week of 1 hour each for a total of 12 weeks. Sessions involve functional, resistance and balance exercises. Intensity is based on rating perceived effort (Borg's scale CR1-10) and volume towards 1 to 3 sets of 6 to 15 repetitions. Progressiveness in intensity and volume was based on effort tolerance, contraction regimen, velocity and load. Training schedule is described elsewhere (Delaire et al, 2023 ; doi.org/10.3390/nu15194100). Participants are allocated to an homogenous group based on functional status and cardiorespiratory comorbidities. Trained kinesiologists supervised the exercise program. Participants used free weights and elastic bands.

Follow-up at T3+6 months:

Investigators interviewed participants for 30 minutes. During the interview, data collection include:record of undesirable events in the interval T3 / T3+6 (falls, unscheduled hospitalization, illness, institutionalization), medication changes, ADL, IADL, FES-I, and RAPA. Goal-settings at T3 are adjusted if not reach. Finally, investigators stimulate intrinsic motivation for PA.

Follow-up at T3 + 12 months:

Investigators re-assessed physical capacity, physical activity level, quality of life, fall risk and frailty for the last visit. Data collection include:

  • SPPB
  • Handgrip test and maximal isometric strength of the quadriceps
  • Questionnaires : SarQoL©, FES-I, RAPA
  • Gait quality analysis using inertial sensors
  • Undesirable events in the interval T3+6 / T3+12 (falls, unscheduled hospitalization, illness, institutionalization)
  • Medication changes
  • Body mass index
  • ADL and IADL At last, goals in physical activity are adjusted if they are still not reach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional status
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Functional status is assessed using the overall SPPB (Short Physical Performance Battery) score based on three components: 6 meters usual walking speed, 5 repetitions chair stand test, and static balance tests. (composite score /12). The SPPB score is calculate from the results in 3 subtests. It ranges from 1 to 12 points. Clinically meaningful change is 1 point.
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of effectiveness on muscle strength : Handgrip test (kg)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
The subject has to perform 3 maximum isometric contractions on a dynamometer which records the force developed. The average of these 3 values will be retained. A value lower than <16kg for women and <27kg for men are considered abnormal and indicate the presence of probable sarcopenia.
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of effectiveness on muscle strength : Maximal isometric strength of the quadriceps (kg)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
The subject has to perform 3 maximum isometric muscular contractions separately against a dynamometer. The best performance (i.e. greatest strength measure) is collected.
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of effectiveness on functional status : 5 repetitions chair stand test (s)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
The subject has to stand with knee extended and sit from a chair 5 times without stopping
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of effectiveness on functional status : Time in TUG (s)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
The subject must get up from a chair, walk at usual speed 3 meters, turn around, and sit down again. A value greater than or equal to 20 seconds will be considered abnormal.
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of effectiveness on functional status : Lower body muscle power measured by a one sit-to-stand test perform at maximum speed (Neurocom Balance Master, Medimex®, France)
Time Frame: initial assessment (baseline), following the exercise program (month 3)
Estimation of lower limb muscle power based on the mean of the 3 repetitions of a sit-to-stand test perform separately. For each transfer, the lifting index (as a % of body weight), reaction time (s), the oscillation limit of the center of gravity, and the symmetry of the supports are measured
initial assessment (baseline), following the exercise program (month 3)
Evaluation of effectiveness on functional status : Gait quality analysis using inertial sensors (GaitUp, MindMaze®, Switzerland)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
A 50 meters walking test perform at usual speed is realized. Data collection include : gait speed, gait variability, gait asymmetry, % flight time, % support time, % double support time, angle of attack, push-off angle, step height, step length, number of cycles in the U-turn, angles in the U-turn
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of muscle mass : SMI measured by bio-impedance analysis (kg.m2)
Time Frame: initial assessment (baseline), following the exercise program (month 3)
SMI is a relative index which is computed from the Sergi equation. Cut-off points are <7,0 and <5,5 for men and women respectively and are considered abnormal. These are the reference values for sarcopenia diagnosis.
initial assessment (baseline), following the exercise program (month 3)
Evaluation of muscle mass : Ultrasonography of the vastus lateralis
Time Frame: initial assessment (baseline), following the exercise program (month 3)
Data collection of muscle density (cm)
initial assessment (baseline), following the exercise program (month 3)
Evaluation of muscle mass : Ultrasonography of the vastus lateralis
Time Frame: initial assessment (baseline), following the exercise program (month 3)
Data collection include of pennation angle (degree)
initial assessment (baseline), following the exercise program (month 3)
Evaluation of muscle mass : Ultrasonography of the vastus lateralis
Time Frame: initial assessment (baseline), following the exercise program (month 3)
Data collection include of fiber length (cm)
initial assessment (baseline), following the exercise program (month 3)
Evaluation of dependencies : Katz scale (Activities of Daily Living - ADL)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Katz scale (ADL) consists of 6 questions. Score varies from 0 to 6. The lower the score, the more dependant is the patient
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of dependencies : Lawton scale (Instrumental Activities of Daily Living-IADL)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Lawton scale (IADL) consists of 8 questions. Score varies from 0 to 8. The lower the score, the more dependant is the patient.
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Record of undesirable events : Falls, unscheduled hospitalization, illness, institutionalization
Time Frame: initial assessment (baseline), following the exercise program (month 3), 6 months following the exercise program (month 9), last visit (month 15)

Data are collected between intervals :

T3/T3+6 and T3+6/T3+12

initial assessment (baseline), following the exercise program (month 3), 6 months following the exercise program (month 9), last visit (month 15)
Evaluation of fear of falling : FES-I questionnaire (/64)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

The validated French translated form is used. Questionnaire is self-administrated.

FES-I questionnaire (Falls Efficacy Scale-International) consists of 16 questions. Score varies from 16 to 64.

A fear of falling is considered to be present with score >23.

initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evolution of the level of physical activity : RAPA questionnaire (/10)
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

The RAPA is validated physical activity questionnaire in older adults. The score is calculated from the reported information of each visit.

Score varies from 0 to 10. The higher the score, the more physically active is the patient.

initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of biomarkers : risk of fractures - Calcemia (mmol/L)
Time Frame: initial assessment (baseline), following the exercise program (month 3)
initial assessment (baseline), following the exercise program (month 3)
initial assessment (baseline), following the exercise program (month 3)
Evaluation of biomarkers : risk of fractures - Vitamin D (nmol/L).
Time Frame: initial assessment (baseline), following the exercise program (month 3)
initial assessment (baseline), following the exercise program (month 3)
initial assessment (baseline), following the exercise program (month 3)
Evaluation of biomarkers : exploratory Fibroblast Growth Factor 19 (FGF-19) (pg/L)
Time Frame: initial assessment (baseline), following the exercise program (month 3)
FGF-19 is analysed in plasma samples by ELISA method. Blood sample is collected in routine care.
initial assessment (baseline), following the exercise program (month 3)
Evaluation of biomarkers : nutritional status - Albumin (g/L)
Time Frame: initial assessment (baseline), following the exercise program (month 3)
Albumin (g/L)
initial assessment (baseline), following the exercise program (month 3)
Evaluation of biomarkers : nutritional status - Pre-albumin (g/L)
Time Frame: initial assessment (baseline), following the exercise program (month 3)
Pre-albumin (g/L)
initial assessment (baseline), following the exercise program (month 3)
Evaluation of biomarkers : inflammation C-reactive protein
Time Frame: initial assessment (baseline), following the exercise program (month 3)
initial assessment (baseline), following the exercise program (month 3)
Evaluation of physical frailty : Fried criteria
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Fried criteria include : unvolontary weight loss >5% during the last 12 months, self-reported exhaustion, low gait speed, low grip strength and poor physical activity level. 0 criterion = non frail ; 1-2 criteria = pre-frail ; ≥3 criteria = frail
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of sarcopenia : EWGSOP2
Time Frame: initial assessment (baseline), following the exercise program (month 3)
No sarcopenia = muscle strength and mass normal Probable sarcopenia = low muscle strength, normal muscle mass Sarcopenia = low muscle strength and mass Severe sarcopenia = low muscle strength and mass + poor physical performances
initial assessment (baseline), following the exercise program (month 3)
Evaluation of nutritional status : Mini Nutritional Assessment
Time Frame: initial assessment (baseline), following the exercise program (month 3)
This self-administrated questionnaire consists of 18 questions. Score varies from 0 to 30. From 17 to 24 points : risk of malnutrition Less than 17 points : poor nutritional status
initial assessment (baseline), following the exercise program (month 3)
Evaluation of nutritional status : caloric (kcal) needs and intakes from the dietary survey
Time Frame: initial assessment (baseline), following the exercise program (month 3)
Survey is self-administrated. Needs/Intake are calculated based on the survey.
initial assessment (baseline), following the exercise program (month 3)
Evaluation of nutritional status : protein (g/J) needs and intakes from the dietary survey
Time Frame: initial assessment (baseline), following the exercise program (month 3)
Survey is self-administrated. Needs/Intake are calculated based on the survey.
initial assessment (baseline), following the exercise program (month 3)
Evolution of quality of life : SarQoL© questionnaire
Time Frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
The SarQoL© is a validated questionnaire in sarcopenic older adults. French validated translated form were used. The questionnaire is self-administrated. An overall change of 7,35 points in the questionnaire is considered to be clinically meaningful.
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2018

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

October 1, 2025

Study Registration Dates

First Submitted

January 29, 2018

First Submitted That Met QC Criteria

September 11, 2018

First Posted (Actual)

September 12, 2018

Study Record Updates

Last Update Posted (Estimated)

September 9, 2025

Last Update Submitted That Met QC Criteria

September 8, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Multidimensional assessments

Subscribe